WHO Classifications of Tumors Editorial Board (2022) Urinary and male genital tumours, 5th edn. International Agency for Research on Cancer, Lyon

Moch H, Humprey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs (4th edition). IARC: Lyon

Kauffman EC, Ricketts CJ, Rais-Bahrami S et al (2014) Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11(8):465–475. https://doi.org/10.1038/nrurol.2014.162

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Hamblin MH, Yin KJ (2017) The long noncoding RNA MALAT1: Its physiological and pathophysiological functions. RNA Biol 14(12):1705–1714. https://doi.org/10.1080/15476286.2017.1358347

Article  PubMed  PubMed Central  Google Scholar 

Kuiper RP, Schepens M, Thijssen J et al (2003) Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 12(14):1661–1669. https://doi.org/10.1093/hmg/ddg178

Article  PubMed  Google Scholar 

Argani P (2015) MiT family translocation renal cell carcinoma. Semin Diagn Pathol 32(2):103–113. https://doi.org/10.1053/j.semdp.2015.02.003

Article  PubMed  Google Scholar 

Caliò A, Segala D, Munari E, Brunelli M, Martignoni G (2019) MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge. Cancers (Basel) 11(8):1110. https://doi.org/10.3390/cancers11081110

Article  PubMed  Google Scholar 

Malouf GG, Su X, Yao H et al (2014) Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes. Clin Cancer Res 20(15):4129–4140. https://doi.org/10.1158/1078-0432.CCR-13-3036

Article  PubMed  PubMed Central  Google Scholar 

Xia QY, Wang XT, Fang R et al (2020) Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum. Am J Surg Pathol 44(4):477–489. https://doi.org/10.1097/PAS.0000000000001408

Article  PubMed  Google Scholar 

Caliò A, Harada S, Brunelli M et al (2021) TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1. Mod Pathol 34(4):842–850. https://doi.org/10.1038/s41379-020-00713-6

Article  PubMed  Google Scholar 

Lin R, Flerova E, Wamsley CE et al (2023) Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. Genes Chromosom Cancer 62(6):353–360. https://doi.org/10.1002/gcc.23125

Article  PubMed  Google Scholar 

Argani P, Reuter VE, Zhang L et al (2016) TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity. Am J Surg Pathol 40(11):1484–1495. https://doi.org/10.1097/PAS.0000000000000720

Article  PubMed  PubMed Central  Google Scholar 

Skala SL, Xiao H, Udager AM et al (2018) Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod Pathol 31(1):179–197. https://doi.org/10.1038/modpathol.2017.99

Article  PubMed  Google Scholar 

Kammerer-Jacquet SF, Gandon C, Dugay F et al (2022) Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression. Histopathology 81(2):228–238. https://doi.org/10.1111/his.14683

Article  PubMed  Google Scholar 

Peckova K, Vanecek T, Martinek P et al (2014) Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. Ann Diagn Pathol 18(6):351–357. https://doi.org/10.1016/j.anndiagpath.2014.10.002

Article  PubMed  Google Scholar 

Gupta S, Argani P, Jungbluth AA et al (2019) TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations. Am J Surg Pathol 43(11):1445–1461. https://doi.org/10.1097/PAS.0000000000001307

Article  PubMed  PubMed Central  Google Scholar 

Caliò A, Brunelli M, Segala D et al (2018) t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma. Mod Pathol 31(3):474–487. https://doi.org/10.1038/modpathol.2017.144

Article  PubMed  Google Scholar 

Caliò A, Brunelli M, Segala D et al (2019) VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations. Mod Pathol 32(2):258–268. https://doi.org/10.1038/s41379-018-0128-1

Article  PubMed  Google Scholar 

Kojima F, Kuroda N, Matsuzaki I et al (2019) Aggressive TFEB-rearranged renal cell carcinoma mimicking chromophobe and clear cell renal cell carcinoma. Pathol Int 69(1):51–53. https://doi.org/10.1111/pin.12744

Article  PubMed  Google Scholar 

Caliò A, Marletta S, Brunelli M et al (2022) TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. Virchows Arch 481(6):877–891. https://doi.org/10.1007/s00428-022-03380-x

Article  PubMed  PubMed Central  Google Scholar 

Inamura K (2017) Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features. Cancers (Basel) 9(9):111. https://doi.org/10.3390/cancers9090111

Article  PubMed  Google Scholar 

Gupta S, Johnson SH, Vasmatzis G et al (2017) TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol 30(7):998–1012. https://doi.org/10.1038/modpathol.2017.24

Article  PubMed  Google Scholar 

Kammerer-Jacquet SF, Deleuze A, Saout J, Mathieu R, Laguerre B, Verhoest G, Dugay F, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N (2019) Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma. Int J Mol Sci 20(7):1692. https://doi.org/10.3390/ijms20071692

Article  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, et al (2016) Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 374(2):135–145. https://doi.org/10.1056/NEJMoa1505917

Williamson SR, Grignon DJ, Cheng L et al (2017) Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis? Am J Surg Pathol 41(3):287–298. https://doi.org/10.1097/PAS.0000000000000776

Article  PubMed  Google Scholar 

Mendel L, Ambrosetti D, Bodokh Y et al (2018) Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome. Genes Chromosom Cancer 57(3):99–113. https://doi.org/10.1002/gcc.22513

Article  PubMed  Google Scholar